中文 | English
Return
Total: 2619 , 1/262
Show Home Prev Next End page: GO
Author:( Bo FENG)

1.DPP-4 inhibitors and glucose homeostasis - From cell to bedside

Bo FENG

Chinese Journal of Endocrinology and Metabolism 2012;28(6):525-526

2.Segmental splenectomy, the first choice for treatment of splenic benign tumor

Bo HUANG ; Bianxi FENG

Chinese Journal of Hepatobiliary Surgery 2010;16(6):410-412

3.Relationships among measures of gait recovery and community integration index in people with brain injury

Bo FENG ; Wei XU

Chinese Journal of Primary Medicine and Pharmacy 2015;(14):2203-2205

4.Simultaneous Determination of 6 Kinds of Components in Longze Xiongdan Capsules by HPLC

Chengyi HAO ; Bo FENG

China Pharmacy 2017;28(9):1246-1249

5.Content Determination of Oleanolic Acid and Ursolic Acid in Prunella vulgaris by HPLC

Shuying GUO ; Bo FENG

China Pharmacy 2007;0(27):-

7.Liraglutide alleviates arteriosclerotic lesions and inhibits receptor for advanced glycation end-product expression in diabetic ApoE-/- mice

Peicheng LI ; Bo FENG

Chinese Journal of Endocrinology and Metabolism 2016;32(8):680-684

8.Changes of arterial blood pressure variability and baroreflex sensitivity in diabetic patients

Bo FENG ; Yafang NI

Chinese Journal of Endocrinology and Metabolism 2001;0(05):-

9.13C-octanoic acid breath test for measurement of solid gastric emptying: reproducibility in normal subjects and patients with diabetes mellitus

Bo, FENG ; Ziegler, DAN

Chinese Journal of Nuclear Medicine 2001;21(2):107-108

10.Inhibitory effect of 4'-methylether-scutellarein on human choriocarcinoma JAR cells and the possible mechanism

Bo FENG ; Changfen XU

Chinese Journal of Cancer Biotherapy 2006;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2619 , 1/262 Show Home Prev Next End page: GO